From the Prospective Epidemiological Risk Factor (PERF) study group, Center for Clinical and Basic Research, Ballerup, Denmark (L.B.T., P.A., Y.Z.B., C.C.); the Department of Endocrinology and Metabolism C, Århus Amtssygehus, Århus University, Århus, Denmark (J.M.B., B.R.); and Rheoscience, Rødovre, Denmark (P.J.L.).(2004-10-12時点)